Anaplastic Astrocytoma
Showing NaN - NaN of 9
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Chicago, Baltimore, Saint Paul (PAC-1 Compound)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- PAC-1 Compound
-
Chicago, Illinois
- +2 more
Sep 18, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)
Terminated
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Toca 511
- +4 more
-
Phoenix, Arizona
- +66 more
Feb 6, 2020
Glioblastoma, Anaplastic Astrocytoma Trial in Baltimore (Fingolimod)
Completed
- Glioblastoma
- Anaplastic Astrocytoma
-
Baltimore, MarylandThe Johns Hopkins University
Sep 12, 2017
Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)
Unknown status
- Malignant Glioma
- +5 more
-
Birmingham, Alabama
- +18 more
Apr 1, 2009